Physiomics PLC
LSE:PYC
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.265
1.125
|
| Price Target |
|
We'll email you a reminder when the closing price reaches GBX.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Physiomics PLC
Physiomics Plc engages in the provision of outsourced systems and computational biology services to pharmaceutical companies. The company is headquartered in Oxford, Oxfordshire and currently employs 7 full-time employees. The company went IPO on 2004-12-20. The firm offer Virtual Tumour technology and other tools to predict the effects of cancer treatments. The Company’s Virtual Tumour software platform is used to simulate the effects of anti-cancer agents on pre-clinical and human tumors. The company is used by companies ranging from startup biotech to global large-cap pharmaceuticals. The firm provides a range of Pharmacokinetic/Pharmacodynamics (PK/PD) services, usually in support of smaller companies where this function is outsourced. The Company’s services include oncology specialists, mechanistic modelling, PK/PD, quantitative systems pharmacology and mathematical modelling.
Physiomics Plc engages in the provision of outsourced systems and computational biology services to pharmaceutical companies. The company is headquartered in Oxford, Oxfordshire and currently employs 7 full-time employees. The company went IPO on 2004-12-20. The firm offer Virtual Tumour technology and other tools to predict the effects of cancer treatments. The Company’s Virtual Tumour software platform is used to simulate the effects of anti-cancer agents on pre-clinical and human tumors. The company is used by companies ranging from startup biotech to global large-cap pharmaceuticals. The firm provides a range of Pharmacokinetic/Pharmacodynamics (PK/PD) services, usually in support of smaller companies where this function is outsourced. The Company’s services include oncology specialists, mechanistic modelling, PK/PD, quantitative systems pharmacology and mathematical modelling.
